Literature DB >> 12957672

Synthesis, X-ray crystal structures and biological activity of 16-amino-17-substituted-D-homo steroid derivatives.

Katarina M Penov Gasi1, Dusan A Miljković, Ljubica D Medić Mijacević, Evgenija A Djurendić, Srdjan Z Stojanović, Marija N Sakac, Maja Dj Djurendić, Slobodanka M Stanković, Dusan Lazar, Silvana Andrić, Radmila Kovacević.   

Abstract

D-Homo derivatives in the androstane and estrane series, 12-19, were synthesized by a fragmentation-cyclization reaction of 16-oximino-17-hydroxy-17-substituted derivatives 3-9, or by cyclization of the corresponding D-seco derivatives 20-26. The structures were confirmed by X-ray analysis of compounds 12 and 16. Preliminary assessment of inhibitory effects of D-homo derivatives from androstane series towards aromatase, 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD), 17 alpha-hydroxylase/C17-20 lyase (P450c17) and 17 beta-HSD indicated much lower inhibitory potential compared to previously tested activity of another type of D-modified steroids, namely D-seco derivatives. Also, assessment of potential antiestrogenic activity of derivatives from estrane series showed absence of such an activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957672     DOI: 10.1016/s0039-128x(03)00097-7

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  2 in total

1.  In silico assay development for screening of tetracyclic triterpenoids as anticancer agents against human breast cancer cell line MCF7.

Authors:  Om Prakash; Ateeque Ahmad; Vinay Kumar Tripathi; Sudeep Tandon; Aditya Bhusan Pant; Feroz Khan
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

2.  Synthesis and structure-activity relationships of 2- and/or 4-halogenated 13β- and 13α-estrone derivatives as enzyme inhibitors of estrogen biosynthesis.

Authors:  Ildikó Bacsa; Bianka Edina Herman; Rebeka Jójárt; Kevin Stefán Herman; János Wölfling; Gyula Schneider; Mónika Varga; Csaba Tömböly; Tea Lanišnik Rižner; Mihály Szécsi; Erzsébet Mernyák
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.